Abstract
Nonsteroidal anti-inflammatory drugs are suggested to have anti-cancer effects in many studies, but elucidation of mode of action remains a challenging task. The present study was aimed to evaluate the effect of an Aryl hydrazone derivative of Naproxen (AHD) on HepG2 liver cancer cells and HGF gingival fibroblasts. The mentioned cell lines were randomly divided into control groups and test groups exposed to 1, 10, 20, 50, and 100 μg/mL of Naproxen and (AHD). The cytotoxic effects of the compounds were measured using the MTT assay. The rate of apoptosis and cell cycle were also evaluated using flow cytometry at 24 and 48 h. The data were compared between groups using one-way analysis of variance. The results showed a significantly reduced viability of liver cancer cells by 20, 50, and 100 μg/mL of Naproxen, and AHD after 24 h (IC50 = 51.35 μg/ mL and IC50 = 87.05 μg/ mL) and 48 h (IC50 = 24.92 μg/ mL and IC50 = 20.82 μg/ mL) (p < 0.0001). Exposure to Naproxen and AHD increased the late apoptosis rate 9.10 and 6.42 times respectively in HepG2 cancer cells compared to the control group at 48 h. (**** p < 0.0001). In the group treated with AHD, a significant decrease in G1 and a significant increase in S and G2 phases occurred in the percentage of arrested cells in HepG2 cancer at 24 h (****p < 0.0001). A significant decrease in G1 and a significant increase in S phases of Naproxen and AHD occurred in the percentage of arrested cells on HepG2 cancer at 48 h (***p < 0.001, **p < 0.01, ****p < 0.0001 ***p < 0.001 respectively). The results of this study demonstrate that Naproxen and the evaluated AHD induce cytotoxic effects in the HepG2 cancer cell line through the apoptosis pathway by cell arrest in the G2/M phase. The less cytotoxicity was observed in gingival fibroblasts than in cancer cells.
Similar content being viewed by others
Data availability
The raw/processed data required to reproduce these findings cannot be shared at this time due to legal or ethical reasons.
References
Abdel-Aziz AA, El-Azab AS, AlSaif NA, Obaidullah AJ, et al. Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study. J Enzyme Inhib Med Chem. 2021;36:1520–38. https://doi.org/10.1080/14756366.2021.1924698.
Almasirad A, Tajik M, Bakhtiari D, Shafiee A, et al. Synthesis and analgesic activity of N-arylhydrazone derivatives of mefenamic acid. J Pharm Pharm Sci. 2005;8:419–25.
Álvarez CS, Espinosa-Tamez P, López-Ridaura R, Lamadrid-Figueroa H, Melchor-Ruan J, McGlynn KA, Lajous M. Liver cancer mortality in Mexico: trend analysis from 1998 to 2018. Salud Pública Méx. 2022. https://doi.org/10.21149/12518.
Aytaç P, Sahin ID, Atalay RÇ, Tozkoparan B, et al. Design, synthesis and biological evaluation of novel triazolothiadiazoles derived from NSAIDs as anticancer agents. Anticancer Agents Med Chem. 2022;22:1340–7. https://doi.org/10.2174/1871520621666210623093550.
Azizian H, Mousavi Z, Faraji H, Tajik M, et al. Arylhydrazone derivatives of naproxen as new analgesic and anti-inflammatory agents: design, synthesis and molecular docking studies. J Mol Graph Model. 2016;67:127–36. https://doi.org/10.1016/j.jmgm.2016.05.009.
Bhattacharya A, Nakka M, Begum MS, Varaprasad BM, et al. Naproxen and ibuprofen based acyl hydrazone derivatives: synthesis, structure analysis and cytotoxicity studies. J Chem Pharm Res. 2010;2:393–409.
Birgül K, Uba AI, Çuhadar O, Sevinç SK, et al. Synthesis and molecular modeling of MetAP2 of thiosemicarbazides, 1, 2, 4-triazoles, thioethers derived from (S)-naproxen as possible breast cancer agents. J Struct Mol. 2022;125:132739. https://doi.org/10.1016/j.molstruc.2022.132739.
Galisteo A, Jannus F, García-García A, Aheget H, et al. Diclofenac N-derivatives as therapeutic agents with anti-inflammatory and anti-cancer effect. Int J Mol Sci. 2021;2:5067. https://doi.org/10.3390/ijms22105067.
Ghazazani Z, Heshmati M, Asgarpanah J, Pashapour S. Evaluation of molecular docking and cytotoxicity by pycnocycla bashagardiana fruit essential oil in colon cancer cell lines. J Kermanshah Univ Med Sci. 2023. https://doi.org/10.5812/jkums-131043.
Guégan JP, Lapouge M, Voisin L, Saba-El-Leil MK, et al. Signaling by the tyrosine kinase yes promotes liver cancer development. Sci Signal. 2022;15:eabj4743. https://doi.org/10.1126/scisignal.abj4743.
Han MI, Atalay P, Tunç CÜ, Ünal G, et al. Design and synthesis of novel (S)-Naproxen hydrazide-hydrazones as potent VEGFR-2 inhibitors and their evaluation in vitro/in vivo breast cancer models. Bioorg Med Chem. 2021;37:116097. https://doi.org/10.1016/j.bmc.2021.116097.
Heshmati M, Abad NH-R, Pashapour S. Evaluating the effects of silymarin on expressing SBDSP1 and CASC11 genes in HCT116 colon cancer cells. J Kermanshah Univ Med Sci. 2022. https://doi.org/10.5812/jkums-122802.
Kim MS, Kim JE, Lim DY, Huang Z, et al. Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K. Cancer Prev Res. 2014;7:236–45. https://doi.org/10.1158/1940-6207.CAPR-13-0288.
Küçükgüzel ŞG, Koç D, Çıkla-Süzgün P, Özsavcı D, et al. Synthesis of tolmetin hydrazide-hydrazones and discovery of a potent apoptosis inducer in colon cancer cells. Arch Pharm. 2015;348:730–42. https://doi.org/10.1002/ardp.201500178.
Leksomboon R, Kumpangnil K, Pangjit K, Udomsuk L. The effects of ibuprofen, naproxen and diclofenac on cell apoptosis, cell proliferation and histology changes in human cholangiocarcinoma cell lines. Asian Pac J Cancer Prev. 2022;23(4):1351–8. https://doi.org/10.31557/APJCP.2022.23.4.1351.
Nematollahzadeh A, Mirzaei-Kalar Z, Abolhasani H, Babapoor A. Synthesize and multi-spectroscopic studies of zinc-naproxen nanodrug as DNA intercalator agent. Anal Biochem. 2022;642:114454. https://doi.org/10.1016/j.ab.2021.114454.
Norouzi S, Ahmadi R, Pashapour S. The cytotoxic effects of Tolmetin on evaluation of Bax and Bcl2 genes expression level in cervical cancer cells (Hela). KAUMS. 2020;24:31–7.
Pashapour S, Heshmati M, Mousavi Z, Esmaeili S. The cytotoxicity of the chloroform and petroleum ether fractional extracts of galium verum L. in HepG2 and HT29 cell lines. J Kerm Uni Medi Sci. 2020;24:e101079. https://doi.org/10.5812/jkums.101079.
Pashapour S, Heshmati M, Mousavi Z, Esmaeili S. The effects of methanolic extract of the aerial parts of galium verum on HT29 and AGO cell lines. Nucleus. 2021;65:223–32. https://doi.org/10.1007/s13237-021-00380-1.
Pashapour S, Heshmati M, Mousavi Z, Esmaeili S. The apoptotic effect of methanolic extract of galium verum on HT29 cell line. JBS. 2022;4:210–20.
Pashapour S, Zabihi A, Behrouzi R. Investigating the cytotoxic effect of ibuprofen concentration in liver cancer cells (HepG2) and normal fibroblast (AGO). Toxicol Adv. 2022;4:15. https://doi.org/10.53388/20220202015.
Salgın-Gökşen U, Gökhan-Kelekçi N, Göktaş Ö, Köysal Y, et al. 1-Acylthiosemicarbazides, 1, 2, 4-triazole-5 (4H)-thiones, 1, 3, 4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities. Bioorg Med Chem. 2007;15:5738–51. https://doi.org/10.1016/j.bmc.2007.06.006.
Sevil Şenkardeş M, Han İ, Gürboğa M, Özakpinar ÖB, Güniz Küçükgüzel Ş. Synthesis and anticancer activity of novel hydrazone linkage-based aryl sulfonate derivatives as apoptosis inducers. Med Chem Res. 2022;31(2):368–79. https://doi.org/10.1007/s00044-021-02837-z.
Wdowiak A, Farahmandlou N, Tajik A, Pashapour S, et al. The cytotoxic effect of estradiol Valerate, progesterone, and testosterone on brain glioblastoma (A172), colorectal cancer (HT29) and human embryonic kidney (HEK293) cells and the expression levels of bax, Bcl-2, and KAI-1/CD82 in A172 and HT29 cells. JBS. 2021;4:106–19.
Zabihi A, Pashapour S, Malakijoo N. Evaluation of cytotoxicity of rubiadine on MCf7 and AGO cell lines. Toxicol Commun. 2022;4(2):9. https://doi.org/10.53388/2022020209.
Acknowledgements
Authors are grateful to the Toxicogenomics Laboratory, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, and all the people who helped to conduct the present research. There is no funding.
Author information
Authors and Affiliations
Contributions
ZM and AA conceived the idea of research, ZM supervised all anti-cancer evaluations, AA carried out the design and supervision of the synthesis of AHD. RSML performed MTT assay, Flow cytometry and statistical analysis. ZM and SP wrote/revised the manuscript. The results of this study are based on the Pharm. D. thesis of (RSML) presented by the Toxicogenomics Laboratory of Islamic Azad University of Medical Sciences.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest regarding the publication of this article.
Ethical approval
The Study protocol was approved by the ethics committee of the Pharmaceutical Sciences Branch of the Islamic Azad University, Tehran.
Informed consent
All authors have read and approved the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding Editor: Somnath Paul; Reviewers: Suman Bala, Sepideh Arbabi
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lavasani, R.S.M., Pashapour, S., Almasirad, A. et al. Effects of an aryl hydrazone derivative of naproxen on HepG2 liver cancer and HGF gingival fibroblasts cell lines. Nucleus 66, 183–193 (2023). https://doi.org/10.1007/s13237-023-00428-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13237-023-00428-4